Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Lumito

4.39 SEK

-5.49 %

Less than 1K followers

LUMITO

Nordic SME

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lumito

2019202020212022202320242025
Revenue0.1
growth-%
EBITDA-7.9-16.1-26.3-27.2-26.4-26.2-22.4
EBIT-7.9-16.1-26.4-27.3-26.5-38.3-41.9
Profit before taxes-7.9-16.0-26.4-27.0-25.8-41.6-43.9
Net income-7.9-16.0-26.4-27.0-25.8-41.6-43.9
EPS-27.58-33.09-47.88-29.43-5.52-33.11-45.00
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-26,160.0 %
EBIT-%-38,300.0 %
ROE-12.7 %-17.1 %-23.4 %-20.8 %-25.0 %-44.8 %-58.0 %
ROI-11.6 %-16.3 %-21.8 %-19.8 %-21.2 %-37.1 %-50.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.